It is important to note that diabetes mellitus is associated with a poorer prognosis in cancer patients, and may therefore confound the results by predisposing the non‐PPAR‐γ‐Activating ARBs group to a poorer prognosis.32 Here, PPARG is linked to diabetes mellitus.